Skip to main content

Together we are beating cancer

Donate now

Phil Prime

Showing 12 out of 65 results

We recently welcomed some early career researchers to observe some of the panel discussions and interviews for our Research Careers Committee. So, how did they get on? We recently welcomed some early career researchers to observe some of the panel discussions and interviews for our Research Careers Committee. So, how did they get on?

by Phil Prime | In depth | 6 July 2022

6 July 2022

Nobody fully understands why people go off food in response to infection, early pregnancy and some chemotherapies for cancer. A flurry of research published in recent years has narrowed down the search for the culprit mechanism, and Cancer Research UK-funded researchers have just found another piece of the puzzle. Nobody fully understands why people go off food in response to infection, early pregnancy and some chemotherapies for cancer. A flurry of research published in recent years has narrowed down the search for the culprit mechanism, and Cancer Research UK-funded researchers have just found another piece of the puzzle.

by Phil Prime | In depth | 15 June 2022

15 June 2022

This episode features Professor Sara Zanivan. She talks about how understanding the tumour microenvironment has developed over the past 20 years, how the techniques of proteomics have really freed researchers to ask the important questions and why we could even see mass-spec proteomics in the clinic. This episode features Professor Sara Zanivan. She talks about how understanding the tumour microenvironment has developed over the past 20 years, how the techniques of proteomics have really freed researchers to ask the important questions and why we could even see mass-spec proteomics in the clinic.

by Phil Prime | Podcast | 23 May 2022

23 May 2022

This entry is part 3 of 9 in the series Cancer Research Matters - series 1

Find out what a Registered Report is, how you can get involved, and why this relatively small change in the way research is done could have a real impact on reproducibility issues and even patient outcomes. Find out what a Registered Report is, how you can get involved, and why this relatively small change in the way research is done could have a real impact on reproducibility issues and even patient outcomes.

by Phil Prime | Interview | 16 May 2022

16 May 2022

Executive Director of Research and Innovation, Iain Foulkes introduces our new innovation engine – Cancer Research Horizons Executive Director of Research and Innovation, Iain Foulkes introduces our new innovation engine – Cancer Research Horizons

by Phil Prime | Analysis | 3 May 2022

3 May 2022

We invited our clinical research community to pose us questions to make sure we are doing all we can to help the recovery of cancer clinical trials to pre-pandemic levels We invited our clinical research community to pose us questions to make sure we are doing all we can to help the recovery of cancer clinical trials to pre-pandemic levels

by Phil Prime | Interview | 29 April 2022

29 April 2022

We are jointly funding a follow-up study which will find the final evidence on the impact on oesophageal cancer mortality of screening using the Cytosponge. We are jointly funding a follow-up study which will find the final evidence on the impact on oesophageal cancer mortality of screening using the Cytosponge.

by Phil Prime | In depth | 28 April 2022

28 April 2022

Cancer Research UK is making it easier for the cancer research community to both contribute and access research tools Cancer Research UK is making it easier for the cancer research community to both contribute and access research tools

by Phil Prime | In depth | 11 April 2022

11 April 2022

We spoke to Professor Andrew Tutt about how you build a successful scientific team, the importance of translation and why you always need a touch of humbleness… We spoke to Professor Andrew Tutt about how you build a successful scientific team, the importance of translation and why you always need a touch of humbleness…

by Phil Prime | Interview | 10 April 2022

10 April 2022

We answer questions from the research community about our refreshed Research Strategy We answer questions from the research community about our refreshed Research Strategy

by Phil Prime | Interview | 29 March 2022

29 March 2022

The episode features Steve Jackson. Steve is the University of Cambridge Frederick James Quick Professor of Biology. He is also Head of Cancer Research UK Laboratories at the Wellcome Trust/Cancer Research UK Gurdon Institute. He talks about the difference between academic and commercial science, tips for forming a spinout company and what we should aim for in the next 20 years of cancer research. The episode features Steve Jackson. Steve is the University of Cambridge Frederick James Quick Professor of Biology. He is also Head of Cancer Research UK Laboratories at the Wellcome Trust/Cancer Research UK Gurdon Institute. He talks about the difference between academic and commercial science, tips for forming a spinout company and what we should aim for in the next 20 years of cancer research.

by Phil Prime | Podcast | 23 March 2022

23 March 2022

This entry is part 2 of 9 in the series Cancer Research Matters - series 1